Skip to Content

M2Bio Sciences Inc WUHN

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

WUHN is trading at a 37% discount.
Price
$0.00
Fair Value
$8.47
Uncertainty
Extreme
1-Star Price
$3.77
5-Star Price
$1.57
Economic Moat
Fvjqm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if WUHN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.05
Bid/Ask
$0.00 / $0.12
Market Cap
$33.93
Volume/Avg
1,200 / 61,938

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

M2Bio Sciences Inc is a United States-based nutraceutical biotechnology company. It focuses on alternative plant-based cannabinoids and psilocybin medical research that is into the development and commercialization of CBD and mushrooms-based products. The company's brands include Dr. AnnaRx, Medspresso, and Handcrafted Delight. It is also into research with psilocybin that aims to develop new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
3

Valuation

Metric
WUHN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
WUHN
Quick Ratio
0.59
Current Ratio
1.10
Interest Coverage
−0.01
Quick Ratio
No chart available

Profitability

Metric
WUHN
Return on Assets (Normalized)
−3.05%
Return on Equity (Normalized)
−7.80%
Return on Invested Capital (Normalized)
−1.15%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class APgt$90.0 Bil
MKKGY
Merck KGaA ADRXtxwjl$73.9 Bil
HLN
Haleon PLC ADRNmn$38.1 Bil
VTRS
Viatris IncFcwn$16.0 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRJzzpw$14.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRNxgh$12.8 Bil
CTLT
Catalent IncLdcyhq$10.6 Bil
PRGO
Perrigo Co PLCXkcj$4.3 Bil
CURLF
Curaleaf Holdings IncWwy$3.8 Bil
PBH
Prestige Consumer Healthcare IncQgxkpys$3.4 Bil

Sponsor Center